$KVUE
Kenvue Inc.

2024 Q2 Form 10-Q Financial Statement

#000194404824000100 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $4.000B $3.894B $3.852B
YoY Change 3.84% 3.37% 7.3%
Cost Of Revenue $1.635B $1.652B $1.727B
YoY Change -5.33% -2.42% 5.69%
Gross Profit $2.365B $2.242B $2.125B
YoY Change 11.29% 8.1% 8.64%
Gross Profit Margin 59.13% 57.58% 55.17%
Selling, General & Admin $1.641B $1.573B $1.502B
YoY Change 9.25% 10.31% 11.26%
% of Gross Profit 69.39% 70.16% 70.68%
Research & Development $105.0M $100.0M $89.00M
YoY Change 17.98% -2.91% 1.14%
% of Gross Profit 4.44% 4.46% 4.19%
Depreciation & Amortization $69.00M $149.0M $152.0M
YoY Change -54.61% -10.24% -7.88%
% of Gross Profit 2.92% 6.65% 7.15%
Operating Expenses $1.746B $1.673B $1.591B
YoY Change 9.74% 9.42% 10.64%
Operating Profit $154.0M $550.0M $640.0M
YoY Change -75.94% 0.92% 4.75%
Interest Expense -$92.00M -$122.0M $1.000M
YoY Change -9300.0% 542.11%
% of Operating Profit -59.74% -22.18% 0.16%
Other Income/Expense, Net $3.000M -$28.00M -$31.00M
YoY Change -109.68% -3200.0%
Pretax Income $65.00M $427.0M $609.0M
YoY Change -89.33% -16.6% -0.49%
Income Tax $7.000M $131.0M $279.0M
% Of Pretax Income 10.77% 30.68% 45.81%
Net Earnings $58.00M $296.0M $330.0M
YoY Change -82.42% -20.0% -37.5%
Net Earnings / Revenue 1.45% 7.6% 8.57%
Basic Earnings Per Share $0.03 $0.15 $0.19
Diluted Earnings Per Share $0.03 $0.15 $0.19
COMMON SHARES
Basic Shares Outstanding 1.915B shares 1.915B shares 1.716B shares
Diluted Shares Outstanding 1.920B shares 1.920B shares 1.716B shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.014B $1.155B $1.691B
YoY Change -40.04% -6.17%
Cash & Equivalents $1.014B $1.155B $1.691B
Short-Term Investments
Other Short-Term Assets $221.0M $253.0M $175.0M
YoY Change 26.29% -15.1%
Inventory $1.849B $1.884B $2.222B
Prepaid Expenses
Receivables $2.240B $2.160B $2.109B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.881B $6.097B $6.439B
YoY Change -8.67% 3.74%
LONG-TERM ASSETS
Property, Plant & Equipment $2.004B $2.005B $1.836B
YoY Change 9.15% 10.16%
Goodwill $8.973B $9.032B $9.234B
YoY Change -2.83% -1.67%
Intangibles $8.762B $9.378B $9.837B
YoY Change -10.93% -4.82%
Long-Term Investments
YoY Change
Other Assets $617.0M $600.0M $386.0M
YoY Change 59.84% 3.27%
Total Long-Term Assets $20.56B $21.19B $29.16B
YoY Change -29.48% -1.18%
TOTAL ASSETS
Total Short-Term Assets $5.881B $6.097B $6.439B
Total Long-Term Assets $20.56B $21.19B $29.16B
Total Assets $26.44B $27.28B $35.60B
YoY Change -25.71% -0.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.437B $2.602B $1.781B
YoY Change 36.83% 42.26%
Accrued Expenses $1.262B $1.083B $987.0M
YoY Change 27.86% -48.35%
Deferred Revenue
YoY Change
Short-Term Debt $667.0M $766.0M $0.00
YoY Change
Long-Term Debt Due $750.0M $750.0M
YoY Change
Total Short-Term Liabilities $5.937B $6.166B $4.210B
YoY Change 41.02% 57.06%
LONG-TERM LIABILITIES
Long-Term Debt $7.051B $7.033B $7.676B
YoY Change -8.14%
Other Long-Term Liabilities $535.0M $541.0M $516.0M
YoY Change 3.68% -42.51%
Total Long-Term Liabilities $535.0M $541.0M $516.0M
YoY Change 3.68% -42.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.937B $6.166B $4.210B
Total Long-Term Liabilities $535.0M $541.0M $516.0M
Total Liabilities $16.27B $16.66B $15.31B
YoY Change 6.22% 128.4%
SHAREHOLDERS EQUITY
Retained Earnings $17.00M $342.0M
YoY Change
Common Stock $19.00M $19.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.18B $10.62B $20.28B
YoY Change
Total Liabilities & Shareholders Equity $26.44B $27.28B $35.60B
YoY Change -25.71% -0.12%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income $58.00M $296.0M $330.0M
YoY Change -82.42% -20.0% -37.5%
Depreciation, Depletion And Amortization $69.00M $149.0M $152.0M
YoY Change -54.61% -10.24% -7.88%
Cash From Operating Activities $440.0M $287.0M $802.0M
YoY Change -45.14% -55.43% 137.28%
INVESTING ACTIVITIES
Capital Expenditures $90.00M $153.0M $55.00M
YoY Change 63.64% -3.77% 48.65%
Acquisitions
YoY Change
Other Investing Activities $5.000M -$1.000M $0.00
YoY Change -87.5% -100.0%
Cash From Investing Activities -$85.00M -$152.0M -$41.00M
YoY Change 107.32% -8.98% -2.38%
FINANCING ACTIVITIES
Cash Dividend Paid $383.0M $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -490.0M -$326.0M $7.388B
YoY Change -106.63% 417.46% -3618.1%
NET CHANGE
Cash From Operating Activities 440.0M $287.0M $802.0M
Cash From Investing Activities -85.00M -$152.0M -$41.00M
Cash From Financing Activities -490.0M -$326.0M $7.388B
Net Change In Cash -135.0M -$227.0M $8.155B
YoY Change -101.66% -154.83% 9062.92%
FREE CASH FLOW
Cash From Operating Activities $440.0M $287.0M $802.0M
Capital Expenditures $90.00M $153.0M $55.00M
Free Cash Flow $350.0M $134.0M $747.0M
YoY Change -53.15% -72.37% 148.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Gross Profit
GrossProfit
2242000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2125000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1573000000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1502000000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-78000000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1652000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1727000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2024Q1 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebt
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
164000000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
41000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
550000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
640000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-28000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30000000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-95000000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
427000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
609000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1915000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1716000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1920000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1716000000 shares
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
163000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-3000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-14000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-21000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
39000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-298000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
216000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
685000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
11211000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-298000000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
383000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-12000000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
91000000 usd
CY2024Q1 kvue Adjustments To Additional Paid In Capital Post Separation Accounting Adjustments
AdjustmentsToAdditionalPaidInCapitalPostSeparationAccountingAdjustments
183000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
10621000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
19970000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
216000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35000000 usd
CY2023Q2 kvue Net Transfer To Affiliate
NetTransferToAffiliate
318000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20372000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
149000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
152000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
81000000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
35000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4000000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
28000000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
99000000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
124000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63000000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
55000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-181000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2000000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5000000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
10000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
27000000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
272000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
52000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-189000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
287000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
802000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000000 usd
CY2024Q1 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 usd
CY2023Q2 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
14000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41000000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
CY2023Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-12000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
160000000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
7686000000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
383000000 usd
CY2023Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2024Q1 kvue Proceeds From Payments Of Contributions Distributions To Affiliates
ProceedsFromPaymentsOfContributionsDistributionsToAffiliates
0 usd
CY2023Q2 kvue Proceeds From Payments Of Contributions Distributions To Affiliates
ProceedsFromPaymentsOfContributionsDistributionsToAffiliates
-286000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
91000000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000000 usd
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-326000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7388000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-36000000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1382000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1231000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-227000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8155000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1155000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9386000000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
22
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1170000000 usd
CY2023Q3 kvue Stock Issued During The Period Shares Exchange Offer
StockIssuedDuringThePeriodSharesExchangeOffer
1533830450 shares
CY2023Q3 kvue Exchange Of Stock Percent
ExchangeOfStockPercent
0.801
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenue and expenses during the periods reported. Estimates are used when accounting for, among other things, sales discounts, trade promotions, rebates, allowances and incentives, product liabilities, income taxes and related valuation allowance, withholding taxes pension, postretirement benefits, fair value of financial instruments, stock-based compensation assumptions, depreciation, amortization, employee benefits, contingencies, allocations of cost and expenses from J&amp;J and its affiliates, and goodwill and intangible asset and liability valuations. Actual results may or may not differ from those estimates.</span></div>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
25000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
35000000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
38000000 usd
CY2024Q1 kvue Separation Related Costs
SeparationRelatedCosts
67000000 usd
CY2023Q2 kvue Separation Related Costs
SeparationRelatedCosts
98000000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100000000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
140000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
140000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
97000000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
142000000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
141000000 usd
CY2023Q2 kvue Lessee Operating Lease Leased Area
LesseeOperatingLeaseLeasedArea
290000 sqft
CY2024Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P15Y
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
93000000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
93000000 usd
CY2024Q1 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0475
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
93000000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
92000000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
94000000 usd
CY2024Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
68000000 usd
CY2024Q1 us-gaap Supplier Finance Program Payment Timing Period
SupplierFinanceProgramPaymentTimingPeriod
P90D
CY2024Q1 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
267000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
227000000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to current fiscal year presentation.</span></div>
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
609000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
163000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
216000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
19970000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
216000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35000000 usd
CY2023Q2 kvue Net Transfer To Affiliate
NetTransferToAffiliate
318000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20372000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
28000000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
313000000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
304000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
113000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
115000000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1458000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1432000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1884000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1851000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7703000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3510000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4193000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7889000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3518000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4371000000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
12888000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3510000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9378000000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13137000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3518000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9619000000 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
74000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
9271000000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-239000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
9032000000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
68000000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
72000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
7783000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
7687000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2024Q1 kvue Long Term Debt And Lease Obligation Excluding Current Maturities
LongTermDebtAndLeaseObligationExcludingCurrentMaturities
7033000000 usd
CY2023Q4 kvue Long Term Debt And Lease Obligation Excluding Current Maturities
LongTermDebtAndLeaseObligationExcludingCurrentMaturities
7687000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2024Q1 us-gaap Commercial Paper
CommercialPaper
769000000 usd
CY2023Q4 us-gaap Commercial Paper
CommercialPaper
600000000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1000000 usd
CY2024Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
6000000 usd
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
0 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
1522000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
599000000 usd
CY2024Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
8555000000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
8286000000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
109000000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
11000000 usd
CY2024Q1 us-gaap Interest Income Money Market Deposits
InterestIncomeMoneyMarketDeposits
14000000 usd
CY2023Q2 us-gaap Interest Income Money Market Deposits
InterestIncomeMoneyMarketDeposits
10000000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-95000000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1000000 usd
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
7700000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Administration Expenses
DefinedBenefitPlanAdministrationExpenses
16000000 usd
CY2024Q1 kvue Accrued Expenses Current
AccruedExpensesCurrent
429000000 usd
CY2023Q4 kvue Accrued Expenses Current
AccruedExpensesCurrent
465000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
171000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
406000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44000000 usd
CY2024Q1 kvue Deferred Income Taxes And Other Tax Liabilities Current
DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent
170000000 usd
CY2023Q4 kvue Deferred Income Taxes And Other Tax Liabilities Current
DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent
113000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
269000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
428000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1083000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1456000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
173000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
188000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
97000000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
143000000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
141000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
127000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
65000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
541000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
491000000 usd
CY2024Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-299000000 usd
CY2024Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-298000000 usd
CY2023Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
228000000 usd
CY2023Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
12000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
216000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
8000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
33000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13496000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.17
CY2024Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2000000 usd
CY2023Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2024Q1 kvue Royalty Income
RoyaltyIncome
9000000 usd
CY2023Q2 kvue Royalty Income
RoyaltyIncome
7000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
9000000 usd
CY2024Q1 kvue Net Economic Benefits From Deferred Markets
NetEconomicBenefitsFromDeferredMarkets
15000000 usd
CY2023Q2 kvue Net Economic Benefits From Deferred Markets
NetEconomicBenefitsFromDeferredMarkets
0 usd
CY2024Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
68000000 usd
CY2023Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
2000000 usd
CY2023Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-1000000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-78000000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17000000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
4000000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
-16000000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-31000000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-7000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-28000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
174000000 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1919648483 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1914698483 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1716160000 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57601000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
469000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1915000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1716000000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1920000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1716000000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2024Q1 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
66000000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
63000000 usd
CY2024Q1 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
46000000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
75000000 usd
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
364000000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
329000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-21000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
39000000 usd
CY2023Q4 us-gaap Aoci Derivative Qualifying As Hedge Excluded Component After Tax
AociDerivativeQualifyingAsHedgeExcludedComponentAfterTax
7000000 usd
CY2024Q1 us-gaap Aoci Derivative Qualifying As Hedge Excluded Component After Tax
AociDerivativeQualifyingAsHedgeExcludedComponentAfterTax
-7000000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
41000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
71000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2023Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3894000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3852000000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
75000000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
71000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
74000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81000000 usd
CY2024Q1 kvue Separation Related Costs
SeparationRelatedCosts
67000000 usd
CY2023Q2 kvue Separation Related Costs
SeparationRelatedCosts
98000000 usd
CY2024Q1 kvue Restructuring And Operating Model Optimization Initiatives
RestructuringAndOperatingModelOptimizationInitiatives
50000000 usd
CY2023Q2 kvue Restructuring And Operating Model Optimization Initiatives
RestructuringAndOperatingModelOptimizationInitiatives
0 usd
CY2024Q1 kvue Income From Conversion Of Share Based Awards
IncomeFromConversionOfShareBasedAwards
-22000000 usd
CY2023Q2 kvue Income From Conversion Of Share Based Awards
IncomeFromConversionOfShareBasedAwards
0 usd
CY2024Q1 kvue Founders Share Based Awards Expense
FoundersShareBasedAwardsExpense
8000000 usd
CY2023Q2 kvue Founders Share Based Awards Expense
FoundersShareBasedAwardsExpense
0 usd
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
87000000 usd
CY2023Q2 us-gaap Other General Expense
OtherGeneralExpense
69000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
550000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
640000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-28000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30000000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-95000000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
427000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
609000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
41000000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
35000000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001944048-24-000100-index-headers.html Edgar Link pending
0001944048-24-000100-index.html Edgar Link pending
0001944048-24-000100.txt Edgar Link pending
0001944048-24-000100-xbrl.zip Edgar Link pending
a20241qex311ceocertificati.htm Edgar Link pending
a20241qex312cfocertificati.htm Edgar Link pending
a20241qex321ceocertificati.htm Edgar Link pending
a20241qex322cfocertificati.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kvue-20240331.htm Edgar Link pending
kvue-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
kvue-20240331_cal.xml Edgar Link unprocessable
kvue-20240331_def.xml Edgar Link unprocessable
kvue-20240331_lab.xml Edgar Link unprocessable
kvue-20240331_pre.xml Edgar Link unprocessable
kvue-20240331_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending